Download PDF

Other users also viewed these articles

Lipoprotein (a) is a predictor of non-achievement of LDL-C goals in patients with chronic heart disease José Javier Gómez-Barrado; Paula Gómez-Turégano; María Beltrán Moreno; Ana Isabel Fernández-Chamorro; Benjamín Roque Rodríguez; Zineb Kounka;
Clin Investig Arterioscler. 2024;36:278-85
Observational study of patients from a Lipid Unit on lipid-modifying therapy for primary and secondary prevention: ULFI Study Àlex Vila; Estel Pons; Patricia Trinidad García; Daniel Vidal; Sara López; Armand Grau;
Clin Investig Arterioscler. 2023;35:272-9
Impact of therapeutic inertia in lipid-lowering therapy in patients at very high cardiovascular risk Juan Cosín Sales; Carlos Escobar Cervantes; José Javier Gómez-Barrado; José Manuel Andreu Cayuelas; Abel García del Egido; Jorge Joaquín Castro Martín; Ana Isabel Huelmos Rodrigo; Miguel Corbi-Pascual; Ariana Varela Cancelo; Rafael Vidal-Pérez; Leticia Fernandez-Friera; Enrique Santas Olmeda; Almudena Aguilera-Saborido; Antonio Fernández Romero; Antonio Sánchez Hidalgo; Francisco Pérez-Sádaba; Román Freixa-Pamias;
Clin Investig Arterioscler. 2025;37: